<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">dKFdWS3td88ww9JKBMwPjqG</article-id>
      <article-id pub-id-type="other">00010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011001100010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09700210</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011005000070</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dessincronia ventricular e aumento dos n&#237;veis de BNP na estimula&#231;&#227;o apical do ventr&#237;culo direito</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Abreu</surname>
            <given-names>Cl&#225;udia Drummond Guimar&#227;es</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nunes</surname>
            <given-names>Maria do Carmo Pereira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barbosa</surname>
            <given-names>M&#225;rcia Melo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rocha</surname>
            <given-names>Manoel Ot&#225;vio Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Ant&#244;nio Luiz Pinho</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">Minas Gerais</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Minas Gerais</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Belo Horizonte</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Hospital Socor</institution>
        <institution content-type="orgdiv1">Departamento de Ecocardiografia </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>08</month>
        <year>2011</year>
      </pub-date>
      <volume>97</volume>
      <issue>2</issue>
      <fpage>156</fpage>
      <lpage>162</lpage>
      <history>
        <date date-type="rev-recd">
          <day>10</day>
          <month>09</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>04</day>
          <month>09</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>04</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A estimula&#231;&#227;o apical cr&#244;nica do ventr&#237;culo direito pode ocasionar dessincronia ventricular e, secundariamente, altera&#231;&#245;es neuro-humorais e aumento da morbimortalidade card&#237;aca. OBJETIVO: Pesquisar dessincronia ventricular e seus efeitos sobre os n&#237;veis de BNP em pacientes com marca-passo estimulados cronicamente no &#225;pice do ventr&#237;culo direito (VD). M&#201;TODOS: Estudo transversal com 85 pacientes com marca-passo uni ou bicameral, em classe funcional I e II da NYHA e fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo (FEVE) &gt; 35%. A avalia&#231;&#227;o de dessincronia foi realizada utilizando-se v&#225;rias t&#233;cnicas ecocardiogr&#225;ficas, incluindo o Tissue Synchronization Imaging (TSI), com an&#225;lise dos 12 segmentos. O BNP foi dosado junto com o ecocardiograma, por&#233;m com o examinador cego. RESULTADOS: Quarenta e seis mulheres e 39 homens, com idade de 58 &#177; 12 anos, chag&#225;sicos (56%) e hipertensos controlados (62%), foram inclu&#237;dos. A fra&#231;&#227;o de eje&#231;&#227;o do VE foi 52 &#177; 8% e a dura&#231;&#227;o m&#233;dia do QRS de 139 ms (120-180 ms). O BNP mostrou-se alterado em 36,5% da amostra (ponto de corte de 60 pg/ml). Na an&#225;lise multivariada de regress&#227;o linear, o BNP correlacionou-se com a idade (p = 0,024), FEVE (p &lt; 0,0001) e tempo pr&#233;-ejetivo do VE (p = 0,009), que &#233; &#237;ndice de dessincronia intraventricular. CONCLUS&#195;O: Em pacientes com estimula&#231;&#227;o card&#237;aca convencional, est&#225;veis clinicamente, a dessincronia intraventricular foi um preditor independente do aumento dos n&#237;veis de BNP, ap&#243;s ajuste pela idade e FEVE.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Marca-passo artificial</kwd>
        <kwd>disfun&#231;&#227;o ventricular</kwd>
        <kwd>pept&#237;deos natriur&#233;ticos</kwd>
        <kwd>ecocardiografia</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>10</day>
        <month>06</month>
        <year>2011</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>Dessincronia ventricular e aumento dos n&#237;veis de BNP na estimula&#231;&#227;o apical do ventr&#237;culo direito</p>
    <p>
      <bold>Cl&#225;udia Drummond Guimar&#227;es Abreu<sup>I</sup>; Maria do Carmo Pereira Nunes<sup>I,II</sup>; M&#225;rcia Melo Barbosa<sup>II</sup>; Manoel Ot&#225;vio Costa Rocha<sup>I</sup>; Ant&#244;nio Luiz Pinho Ribeiro<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Hospital das Cl&#237;nicas e Faculdade de Medicina da UFMG </p>
    <p><sup>II</sup>Departamento de Ecocardiografia do Hospital Socor, Belo Horizonte, MG - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="nt">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> A estimula&#231;&#227;o apical cr&#244;nica do ventr&#237;culo direito pode ocasionar dessincronia ventricular e, secundariamente, altera&#231;&#245;es neuro-humorais e aumento da morbimortalidade card&#237;aca. </p>
    <p><bold>OBJETIVO:</bold> Pesquisar dessincronia ventricular e seus efeitos sobre os n&#237;veis de BNP em pacientes com marca-passo estimulados cronicamente no &#225;pice do ventr&#237;culo direito (VD). </p>
    <p><bold>M&#201;TODOS:</bold> Estudo transversal com 85 pacientes com marca-passo uni ou bicameral, em classe funcional I e II da NYHA e fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo (FEVE) <underline>&gt;</underline> 35%. A avalia&#231;&#227;o de dessincronia foi realizada utilizando-se v&#225;rias t&#233;cnicas ecocardiogr&#225;ficas, incluindo o <italic>Tissue Synchronization Imaging</italic> (TSI), com an&#225;lise dos 12 segmentos. O BNP foi dosado junto com o ecocardiograma, por&#233;m com o examinador cego. </p>
    <p><bold>RESULTADOS:</bold> Quarenta e seis mulheres e 39 homens, com idade de 58 &#177; 12 anos, chag&#225;sicos (56%) e hipertensos controlados (62%), foram inclu&#237;dos. A fra&#231;&#227;o de eje&#231;&#227;o do VE foi 52 &#177; 8% e a dura&#231;&#227;o m&#233;dia do QRS de 139 ms (120-180 ms). O BNP mostrou-se alterado em 36,5% da amostra (ponto de corte de 60 pg/ml). Na an&#225;lise multivariada de regress&#227;o linear, o BNP correlacionou-se com a idade (p = 0,024), FEVE (p &lt; 0,0001) e tempo pr&#233;-ejetivo do VE (p = 0,009), que &#233; &#237;ndice de dessincronia intraventricular. </p>
    <p><bold>CONCLUS&#195;O:</bold> Em pacientes com estimula&#231;&#227;o card&#237;aca convencional, est&#225;veis clinicamente, a dessincronia intraventricular foi um preditor independente do aumento dos n&#237;veis de BNP, ap&#243;s ajuste pela idade e FEVE.</p>
    <p><bold>Palavras-chave:</bold> Marca-passo artificial, disfun&#231;&#227;o ventricular, pept&#237;deos natriur&#233;ticos, ecocardiografia.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Atualmente, os marca-passos card&#237;acos (MP) representam tratamento efetivo para as bradicardias sintom&#225;ticas causadas pela Doen&#231;a do N&#243; Sinusal (DNS) e bloqueios atrioventriculares (BAV). Durante muitos anos, a regi&#227;o apical do ventr&#237;culo direito (VD) foi um dos s&#237;tios mais utilizados nos implantes convencionais por sua facilidade de acesso e estabilidade do cabo eletrodo<sup>1</sup>. Entretanto, apesar da evidente melhora da qualidade de vida na maioria dos portadores do implante artificial, o bloqueio de ramo esquerdo (BRE) induzido pela estimula&#231;&#227;o apical do ventr&#237;culo direito (EAPVD) pode ocasionar altera&#231;&#245;es hemodin&#226;micas, estruturais e funcionais do cora&#231;&#227;o, com consequ&#234;ncias delet&#233;rias sobre a evolu&#231;&#227;o cl&#237;nica de alguns pacientes<sup>2,3</sup>. </p>
    <p>A estimula&#231;&#227;o card&#237;aca em qualquer ponto do ventr&#237;culo altera o padr&#227;o natural de ativa&#231;&#227;o e contra&#231;&#227;o card&#237;acas, j&#225; que a velocidade de condu&#231;&#227;o do est&#237;mulo &#233; mais lenta atrav&#233;s do mioc&#225;rdio ventricular se comparada &#224; efetuada pelo sistema especializado His-Purkinje<sup>4</sup>. </p>
    <p>Estudos j&#225; demonstraram que, em resposta ao est&#237;mulo artificial, as fibras mioc&#225;rdicas se contraem de maneira desorganizada, provocando estiramentos heterog&#234;neos de segmentos mioc&#225;rdicos que podem interferir no metabolismo da c&#233;lula card&#237;aca e causar deteriora&#231;&#227;o global do funcionamento do &#243;rg&#227;o<sup>5,6</sup>. Portanto, poder&#237;amos pressupor que uma sequ&#234;ncia el&#233;trica anormal de ativa&#231;&#227;o ventricular associada ao estiramento inapropriado das paredes do ventr&#237;culo poderia causar dessincronismo entre a atividade el&#233;trica ventricular e sua contratilidade, determinando, em longo prazo, disfun&#231;&#227;o ventricular, altera&#231;&#245;es neuro-humorais e aumento da morbidade e mortalidade card&#237;acas.</p>
    <p>Baseado nessa hip&#243;tese, o principal objetivo do estudo consistiu em avaliar a presen&#231;a de dessincronia ventricular ap&#243;s a EAPVD cr&#244;nica e seus efeitos sobre os n&#237;veis de BNP, em pacientes est&#225;veis clinicamente e sem disfun&#231;&#227;o importante do VE.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>O estudo foi realizado no Laborat&#243;rio de Marca-passo do Servi&#231;o de Cardiologia do Hospital das Cl&#237;nicas da Universidade Federal de Minas Gerais (UFMG) e no Centro de Ecocardiografia do Hospital Socor, ap&#243;s ser aprovado pelos Comit&#234;s de &#201;tica da UFMG e dos hospitais envolvidos. Todos os pacientes assinaram o termo de consentimento livre e esclarecido.</p>
    <p>No per&#237;odo de junho de 2007 a mar&#231;o de 2008, foram selecionados consecutivamente durante as avalia&#231;&#245;es telem&#233;tricas de rotina realizadas no referido Laborat&#243;rio 85 pacientes portadores de marca-passos uni ou bicamerais com estimula&#231;&#227;o apical do VD, chag&#225;sicos e n&#227;o chag&#225;sicos, dependentes da estimula&#231;&#227;o artificial (percentual de estimula&#231;&#227;o de VD <underline>&gt;</underline> 80%) e com padr&#227;o de ativa&#231;&#227;o ventricular tipo BRE no eletrocardiograma (ECG) de superf&#237;cie. </p>
    <p>Foram inclu&#237;dos pacientes de ambos os sexos de 18 a 75 anos, em classe funcional I e II da NYHA e com fra&#231;&#227;o de eje&#231;&#227;o do ventr&#237;culo esquerdo (FEVE) <underline>&gt;</underline> 35%. As doen&#231;as preexistentes e medica&#231;&#245;es em uso foram identificadas.</p>
    <p>Hipertens&#227;o arterial sist&#234;mica (HAS) foi definida como hist&#243;ria cl&#237;nica de hipertens&#227;o e valores de press&#227;o arterial sist&#243;lica (PAS) <underline>&gt;</underline> que 140 mmHg ou de press&#227;o arterial diast&#243;lica (PAD) <underline>&gt;</underline> 90 mmHg. Foram inclu&#237;dos somente hipertensos controlados ou normotensos. </p>
    <p>Diabete melito foi definido como hist&#243;ria cl&#237;nica de diabete e uso regular de hipoglicemiantes orais e/ou insulina, sendo inclu&#237;dos somente diab&#233;ticos com n&#237;veis glic&#234;micos controlados.</p>
    <p>A doen&#231;a de Chagas foi identificada pela presen&#231;a de pelo menos dois exames sorol&#243;gicos distintos positivos (ELISA, hemaglutina&#231;&#227;o indireta ou imunofluoresc&#234;ncia indireta) e hist&#243;ria epidemiol&#243;gica relevante.</p>
    <p>A fun&#231;&#227;o renal foi avaliada por meio da dosagem de creatinina solicitada pelos m&#233;dicos assistentes, durante o seguimento cl&#237;nico/cardiol&#243;gico de rotina.</p>
    <p>Os crit&#233;rios de exclus&#227;o consideraram doen&#231;a arterial coronariana caracterizada pela presen&#231;a de angina de peito e/ou evid&#234;ncia de d&#233;ficit segmentar da contratilidade do VE ao ecocardiograma, fibrila&#231;&#227;o atrial (FA), doen&#231;a pulmonar (DPOC), gravidez, cirurgia card&#237;aca recente (menos de quatro semanas) ou a recusa em participar do estudo.</p>
    <p>
      <bold>An&#225;lise do complexo QRS e radiografia do t&#243;rax</bold>
    </p>
    <p>A dura&#231;&#227;o do complexo QRS consistiu na medida do intervalo de tempo entre a emiss&#227;o da esp&#237;cula do marca-passo e o final do complexo QRS (ms), avaliada na deriva&#231;&#227;o D2 do eletrocardiograma de superf&#237;cie (ECG).</p>
    <p>O posicionamento do cabo-eletrodo ventricular foi verificado por meio da radiografia de t&#243;rax nas incid&#234;ncias p&#243;stero-anterior e perfil.</p>
    <p>
      <bold>Estudo ecocardiogr&#225;fico</bold>
    </p>
    <p>O protocolo do estudo ecocardiogr&#225;fico constou da obten&#231;&#227;o de imagens uni e bidimensionais, com Doppler pulsado e cont&#237;nuo guiado por mapeamento de fluxo em cores, al&#233;m do Doppler tecidual, incluindo o <italic>Tissue Synchronization Imaging</italic> (TSI), com an&#225;lise dos 12 segmentos.</p>
    <p>Os exames foram realizados por profissional experiente em aparelho da marca Vivid 7 (GE Vingmed Ultrasound AS, Horten, Noruega), equipado com transdutor eletr&#244;nico de frequ&#234;ncia vari&#225;vel (4 a 12 MHz) e alta resolu&#231;&#227;o.</p>
    <p>A dessincronia ventricular foi analisada mediante diferentes t&#233;cnicas ecocardiogr&#225;ficas, respeitando-se as recomenda&#231;&#245;es do atual Consenso da Sociedade Americana de Ecocardiografia<sup>7</sup>. As seguintes medidas foram realizadas: </p>
    <disp-quote>
      <p><italic>1. DifTPEVE-VD -</italic> Diferen&#231;a entre os tempos pr&#233;-ejetivos do VE e VD (atraso interventricular) obtidos por meio do Doppler puls&#225;til (ponto de corte <underline>&gt;</underline> 40 ms);</p>
      <p><italic>2. Retardo SIVPP -</italic> Atraso de contra&#231;&#227;o entre o septo interventricular e a parede posterior ao modo M (ponto de corte: <underline>&gt;</underline> 130 ms);</p>
      <p><italic>3. TPEVE </italic>- Medida do tempo pr&#233;-ejetivo do VE (a&#243;rtico) ao Doppler puls&#225;til (ponto de corte: <underline>&gt;</underline> 140 ms); </p>
      <p><italic>4. MaxDif12seg -</italic> M&#225;xima diferen&#231;a de tempo entre dois segmentos distintos obtidos com a t&#233;cnica do TSI (ponto de corte: &gt; 100 ms);</p>
      <p><italic>5. DP12seg -</italic> An&#225;lise do desvio padr&#227;o dos 12 segmentos supracitados (ponto de corte &gt; 32,6 ms);</p>
      <p><italic>6. Retardo SIVPL -</italic> Atraso de contra&#231;&#227;o entre o septo interventricular e a parede lateral obtida tamb&#233;m pelo TSI (ponto de corte: <underline>&gt;</underline> 65 ms);</p>
    </disp-quote>
    <p>
      <bold>Dosagem do BNP</bold>
    </p>
    <p>A dosagem do BNP foi realizada a partir da coleta de sangue venoso, de prefer&#234;ncia em veia antecubital, com o paciente em posi&#231;&#227;o supina por 30 minutos, antes da realiza&#231;&#227;o do ecocardiograma e com o examinador cego para seus resultados. A press&#227;o arterial e a frequ&#234;ncia card&#237;aca foram medidas antes da coleta. As amostras de sangue total foram colocadas em tubos pl&#225;sticos contendo EDTA (1 mg/ml de sangue) e processadas imediatamente por interm&#233;dio dos kits do <italic>Triage</italic><sup><italic>&#174;</italic></sup><italic> BNP Test</italic> (Biosite<sup>&#174;</sup> Inc., San Diego, EUA). No presente estudo, definiu-se o ponto de corte de 60 pg/ml para os n&#237;veis de BNP, baseando-se esse valor em trabalhos anteriores envolvendo chag&#225;sicos com fun&#231;&#227;o de VE preservada<sup>8,9</sup>.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>As vari&#225;veis categ&#243;ricas foram descritas pelas propor&#231;&#245;es, as cont&#237;nuas, pelas m&#233;dias e desvios-padr&#227;o, medianas e intervalos interquart&#237;licos, conforme padr&#227;o de distribui&#231;&#227;o. Utilizou-se a an&#225;lise de regress&#227;o linear uni e multivariada considerando como vari&#225;vel dependente o BNP. O n&#237;vel de signific&#226;ncia estat&#237;stica foi definido para valores de p menores que 0,05.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Foram inclu&#237;dos somente pacientes clinicamente compensados, em classe funcional I e II da NYHA. Houve predom&#237;nio do modo de estimula&#231;&#227;o dupla c&#226;mara (74%) e o tempo mediano do implante foi de 63 meses (1 - 137 meses), e 94% da amostra apresentavam-se em estimula&#231;&#227;o artificial por seis meses ou mais. O bloqueio atrioventricular total (BAVT) foi a indica&#231;&#227;o mais comum para o implante (85%) e em 48 pacientes (56%) a doen&#231;a de Chagas apresentou-se como a causa da cardiopatia de base. A dura&#231;&#227;o m&#233;dia do QRS foi de 139 &#177; 14,2 ms e nenhum dos pacientes apresentou disfun&#231;&#227;o significativa do VE (FEVE m&#233;dia = 51,8 &#177; 8%). </p>
    <p>Com rela&#231;&#227;o ao VD, as m&#233;dias dos seus &#237;ndices de desempenho apresentaram-se dentro dos limites normais, mesmo ap&#243;s an&#225;lise do subgrupo de pacientes com FEVE <underline>&lt;</underline> 40%. Sua fra&#231;&#227;o de eje&#231;&#227;o m&#233;dia foi de 56,4 &#177; 11,2%. </p>
    <p>A mediana dos n&#237;veis de BNP foi de 38,9 pg/ml com valor m&#237;nimo dosado de 5 pg/ml e m&#225;ximo de 581 pg/ml. Em 34 pacientes (40%), esses n&#237;veis foram considerados elevados (ponto de corte de 60 pg/ml). As principais caracter&#237;sticas cl&#237;nicas, demogr&#225;ficas e par&#226;metros ecocardiogr&#225;ficos avaliados est&#227;o listados na <xref ref-type="table" rid="tab01">tabela 1</xref>. </p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt01.jpg"/></table-wrap>
    <p>A dessincronia interventricular foi observada em 49 pacientes (59,8%), considerando-se a mediana do atraso interventricular. Dessincronia intraventricular significativa foi observada em 77 pacientes (90,6%) quando o par&#226;metro analisado foi a mediana do tempo pr&#233;-ejetivo do VE, assim como quando se analisou o desvio-padr&#227;o e a diferen&#231;a m&#225;xima dos picos sist&#243;licos medidos nos 12 segmentos mioc&#225;rdicos. Da mesma forma, a mediana do atraso de contra&#231;&#227;o entre o septo interventricular e a parede lateral foi significativa em 31 pacientes (36,5%) (<xref ref-type="table" rid="tab02">tab. 2</xref>).</p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt02.jpg"/></table-wrap>
    <p>Na an&#225;lise univariada, a dura&#231;&#227;o do QRS, o tempo de implante, a doen&#231;a de Chagas, a hipertens&#227;o arterial e a maior parte das vari&#225;veis ecocardiogr&#225;ficas n&#227;o apresentaram correla&#231;&#227;o significativa com os n&#237;veis de BNP. Entretanto, idade (r = 0,33, p = 0,002) e FEVE (r = -0,28, p = 0,010) correlacionaram-se significativamente com esse par&#226;metro. Correla&#231;&#227;o significativa tamb&#233;m foi observada entre a medida do tempo pr&#233;-ejetivo do VE (r = 0,27, p = 0,013) e o BNP (<xref ref-type="fig" rid="fig01">fig. 1</xref>). Todas as outras medidas realizadas para avalia&#231;&#227;o de DV n&#227;o mostraram correla&#231;&#227;o significativa com os n&#237;veis do pept&#237;deo em quest&#227;o, independentemente da t&#233;cnica ecocardiogr&#225;fica empregada (<xref ref-type="table" rid="tab03">tab. 3</xref>). A associa&#231;&#227;o positiva entre o TPEVE e os n&#237;veis de BNP permaneceu mesmo quando o primeiro foi analisado como uma vari&#225;vel categ&#243;rica, utilizando-se o ponto de corte recomendado para o diagn&#243;stico de DV segundo a literatura atual (<underline>&gt;</underline> 140 ms) (<xref ref-type="fig" rid="fig02">fig. 2</xref>).</p>
    <fig id="fig01">
      <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gf01.jpg"/></fig>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt03.jpg"/></table-wrap>
    <fig id="fig02">
      <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gf02.jpg"/></fig>
    <p>Na an&#225;lise de regress&#227;o linear m&#250;ltipla, o TPEVE permaneceu como &#250;nico preditor significativo e independente dos n&#237;veis de BNP, mesmo ap&#243;s ajuste para covari&#225;veis, como idade e FEVE. O modelo de regress&#227;o linear obtido revelou, portanto, que quanto mais velho for o paciente; quanto mais grave for a disfun&#231;&#227;o do VE e mais prolongado o tempo pr&#233;-ejetivo do ventr&#237;culo esquerdo (a partir de 140 ms), em m&#233;dia, maiores ser&#227;o os n&#237;veis de BNP.</p>
    <p>Embora n&#227;o tenha sido objetivo principal do estudo, foi realizada an&#225;lise entre os subgrupos de chag&#225;sicos e n&#227;o chag&#225;sicos, e tamb&#233;m entre os diferentes modos de estimula&#231;&#227;o, DDD e VVI. Entretanto, n&#227;o se observaram nesta s&#233;rie diferen&#231;as significativas entre os grupos quando as vari&#225;veis cl&#237;nicas, eletrocardiogr&#225;ficas e ecocardiogr&#225;ficas foram avaliadas, exceto a m&#233;dia da FEVE, que foi menor nos chag&#225;sicos (p = 0,035).</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O presente estudo demonstrou a elevada frequ&#234;ncia de DV em pacientes com MP estimulados cronicamente no &#225;pice do VD e est&#225;veis clinicamente, al&#233;m de uma correla&#231;&#227;o significativa entre o tempo pr&#233;-ejetivo do VE, que &#233; uma medida de dessincronia intraventricular, e os n&#237;veis de BNP. </p>
    <p>O grupo estudado caracterizou-se por idade de 58,5 &#177; 12,6 anos, predom&#237;nio de chag&#225;sicos e aus&#234;ncia de disfun&#231;&#227;o ventricular importante (FEVE: 51,8 &#177; 8,5%). O uso regular de drogas como os inibidores da ECA, betabloqueadores e diur&#233;ticos em mais de 80% dos pacientes avaliados indica que todos estavam em tratamento cl&#237;nico otimizado, em classe funcional I e II da NYHA.</p>
    <p>Cerca de 40% dos pacientes apresentaram n&#237;veis elevados de BNP, considerando-se 60 pg/ml o ponto de corte para os valores dosados. Baseou-se esse dado em estudo pr&#233;vio que analisou chag&#225;sicos com fun&#231;&#227;o ventricular preservada e observou valores m&#233;dios de BNP semelhantes entre o grupo controle e pacientes com FEVE &gt; 40%. N&#237;veis significativamente maiores foram encontrados nos pacientes com FEVE <underline>&lt;</underline> 40%<sup>8</sup>.</p>
    <p>Em concord&#226;ncia com outros trabalhos<sup>9,10</sup>, observou-se que a eleva&#231;&#227;o dos n&#237;veis de BNP correlacionou-se com o aumento da idade (r = 0,33, p = 0,002) e com a piora da FEVE (r = -0,28, p = 0,010). Entretanto, considerando-se que a maior parte da amostra apresentava-se em classe funcional I da NYHA, mais do que o aumento das press&#245;es de enchimento do VE, a DV observada no estudo tamb&#233;m contribuiu para a eleva&#231;&#227;o dos n&#237;veis de BNP. Fato demonstrado mediante a correla&#231;&#227;o significativa entre o tempo pr&#233;-ejetivo do VE e o BNP (r = 0,38, p &lt; 0,0001), independentemente da FEVE e idade.</p>
    <p>Trabalhos anteriores j&#225; verificaram que a ativa&#231;&#227;o dessincr&#244;nica dos ventr&#237;culos pode contribuir para uma hipertrofia assim&#233;trica, desarranjo miofibrilar, aumento da concentra&#231;&#227;o de catecolaminas, ativa&#231;&#227;o neuro-humoral e dist&#250;rbios de perfus&#227;o regional<sup>5</sup>. Os estudos MOST<sup>11</sup>, DAVID<sup>12 </sup>e MADIT II<sup>13</sup>, por sua vez, sinalizaram que a DV pode criar substrato anatomofuncional capaz de comprometer a fun&#231;&#227;o card&#237;aca em longo prazo ao constatar aumento do risco de FA, insufici&#234;ncia mitral e hospitaliza&#231;&#245;es por IC em pacientes com elevada porcentagem de batimentos estimulados no VD, particularmente naqueles com disfun&#231;&#227;o ventricular pr&#233;via ao implante<sup>14</sup>. Entretanto, ainda n&#227;o est&#225; claro se a DV &#233; um fen&#244;meno agudo que poderia deteriorar a fun&#231;&#227;o do VE em longo prazo e, consequentemente, ocasionar IC na aus&#234;ncia de cardiomiopatia<sup>15,16</sup>. </p>
    <p>Nossos resultados concordam, todavia, com outros trabalhos que verificaram que a DV secund&#225;ria &#224; EAPVD cr&#244;nica pode ocasionar preju&#237;zos da fun&#231;&#227;o sist&#243;lica e diast&#243;lica do VE e contribuir para o aumento dos n&#237;veis de BNP. Segundo Chiladakis e cols.<sup>17</sup>, o incremento do volume sist&#243;lico final do VE e do tempo de relaxamento isovolum&#233;trico ocasionados pela EAPVD, em pacientes com FEVE normal, contribuiu para esses achados. Outros autores tamb&#233;m verificaram correla&#231;&#227;o significativa do BNP com a gravidade da DV detectada em pacientes com EAPVD, assim como sintomas iniciais de IC em pacientes com BAVT e FEVE normal, ap&#243;s EAPVD por 6,5 &#177; 5,7 anos<sup>18,19</sup>.</p>
    <p>Atualmente, a DV ocasionada pela EAPVD pode ser quantificada por v&#225;rias t&#233;cnicas ecocardiogr&#225;ficas. Embora muitas medidas possam ser utilizadas, as mais simples e rotineiras t&#234;m apresentado bom desempenho em avalia&#231;&#245;es multic&#234;ntricas<sup>20</sup>. O tempo pr&#233;-ejetivo do VE, por exemplo, avaliado no presente estudo, &#233; &#250;til em quantificar dessincronia intraventricular com boa reprodutibilidade segundo trabalhos pr&#233;vios, como o estudo CARE-HF<sup>21</sup>. Recentemente, S&#225; e cols.<sup>22</sup> observaram prolongamento dessa medida em um pequeno grupo de pacientes, tamb&#233;m, de maioria chag&#225;sica com FEVE normal, ao longo de oito meses. Os autores verificaram que apesar de as medidas do TPEVE n&#227;o atingirem o valor aceito para o diagn&#243;stico de DV (<underline>&gt;</underline> 140 ms), essa foi a &#250;nica medida de DV analisada que apresentou incrementos ao longo do tempo de acompanhamento. Salienta-se que, no estudo em quest&#227;o, a estimula&#231;&#227;o septal predominou sobre a apical, que parece ser mais delet&#233;ria.</p>
    <p>Al&#233;m do TPEVE, alterado em mais de 90% da amostra, as demais medidas ecocardiogr&#225;ficas avaliadas no estudo tamb&#233;m identificaram altera&#231;&#245;es dessincr&#244;nicas inter e intraventriculares, revelando a elevada frequ&#234;ncia desse dist&#250;rbio em pacientes com EAPVD cr&#244;nica. &#205;ndices tais como o atraso interventricular, a m&#225;xima diferen&#231;a e o desvio padr&#227;o dos 12 segmentos apresentaram-se alterados em mais de 50% da amostra. Entretanto, apesar da utilidade das diversas t&#233;cnicas ecocardiogr&#225;ficas empregadas, incluindo a <italic>Tissue Synchronization Imaging</italic>, em quantificar a DV, n&#227;o se evidenciou associa&#231;&#227;o significativa dessas medidas com os n&#237;veis s&#233;ricos de BNP nesse grupo de pacientes, ao contr&#225;rio do TPEVE.</p>
    <p>Nossos resultados corroboram as discuss&#245;es atuais, especialmente no campo da TRC, que buscam responder se as medidas ecocardiogr&#225;ficas utilizadas, at&#233; o momento, para a an&#225;lise de DV, seriam aquelas que melhor definiriam a sua presen&#231;a. Dois importantes estudos prospectivos e multic&#234;ntricos, o PROSPECT<sup>23 </sup>e o ReThinQ<sup>24</sup>, n&#227;o encontraram correla&#231;&#227;o entre as medidas de DV e os benef&#237;cios da TRC ao selecionarem candidatos ao procedimento segundo crit&#233;rios ecocardiogr&#225;ficos. A import&#226;ncia de fatores t&#233;cnicos contribuindo para esses achados foi destacada, em especial, por aspectos relacionados &#224; exequibilidade e reprodutibilidade dos m&#233;todos utilizados. &#201; consenso, entretanto, que a t&#233;cnica do TSI n&#227;o deva ser considerada improdutiva para a an&#225;lise de DV, mas avan&#231;os tecnol&#243;gicos s&#227;o necess&#225;rios para abordagens menos dependentes do operador<sup>20</sup>.</p>
    <p>
      <bold>Limita&#231;&#245;es</bold>
    </p>
    <p>Por se tratar de estudo transversal, foram avaliados pacientes com MP em um determinado momento de seu seguimento cl&#237;nico, o que acarreta limita&#231;&#245;es nos resultados. Embora nossos achados indiquem associa&#231;&#227;o entre a eleva&#231;&#227;o dos n&#237;veis de BNP e DV secund&#225;ria &#224; EAPVD cr&#244;nica, o desenho do estudo n&#227;o permite estabelecer uma rela&#231;&#227;o causal entre essas vari&#225;veis. </p>
    <p>&#201; importante considerar, ainda, que o BNP foi avaliado em conjunto com medidas de DV cujos trabalhos espec&#237;ficos n&#227;o definiram quais seriam os melhores &#237;ndices ou pontos de cortes ideais para a sua an&#225;lise, sendo esse um dos motivos da n&#227;o inclus&#227;o das medidas de dessincronia propostas, at&#233; ent&#227;o, nas Diretrizes atuais de ressincroniza&#231;&#227;o card&#237;aca<sup>25</sup>. Apesar disso, &#233; consenso na literatura atual que as medidas de DV sejam utilizadas em conjunto com os crit&#233;rios cl&#237;nicos na sele&#231;&#227;o de candidatos considerados lim&#237;trofes para a TRC<sup>26</sup>.</p>
    <p>Limita&#231;&#245;es inerentes &#224; t&#233;cnica da <italic>Tissue Synchronization Imaging</italic> devem ser ressaltadas<sup>7</sup>. Destacam-se, entre elas, curvas sist&#243;licas nem sempre contidas dentro do intervalo ejetivo, m&#250;ltiplos picos resultantes de um mesmo segmento mioc&#225;rdico e, em algumas ocasi&#245;es, em vez de um pico bem definido, um plat&#244;, que dificultava a determina&#231;&#227;o do ponto ideal para a medida proposta. </p>
    <p>
      <bold>Conclus&#245;es</bold>
    </p>
    <p>Pacientes com MP estimulados cronicamente no &#225;pice do VD apresentam elevada frequ&#234;ncia de DV, e no presente estudo a dessincronia intraventricular foi identificada por meio da medida do tempo pr&#233;-ejetivo do VE, em cerca de 90% dos pacientes. Al&#233;m disso, essa medida mostrou ser um preditor independente do aumento dos n&#237;veis de BNP, indicando que a DV foi capaz de produzir altera&#231;&#245;es neuro-humorais precocemente em pacientes sem disfun&#231;&#227;o importante do VE. Novos estudos s&#227;o necess&#225;rios para se definir se a DV identificada ao ecocardiograma ou o aumento dos n&#237;veis de BNP, em pacientes com MP estimulados cronicamente no &#225;pice do VD, s&#227;o capazes de predizer evolu&#231;&#227;o desfavor&#225;vel. </p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Claudia Drummond Guimar&#227;es Abreu pela Universidade Federal de Minas Gerais.</p>
    <p>
      <fn id="nt" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Cl&#225;udia Drummond Guimar&#227;es Abreu </p>
        <p> Rua Padre Marinho 49/602 - Santa Efig&#234;nia </p>
        <p> 30140-040 - Belo Horizonte, MG - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="abreuoi@oi.com.br">abreuoi@oi.com.br</email>, </p>
        <p>
          <email xlink:href="cdga@hc.ufmg.br">cdga@hc.ufmg.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 04/09/10, Revisado recebido em 10/09/10, aceito em 06/04/11.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Melo CS. Temas de marca-passo. 2&#350; ed. S&#227;o Paulo: Lemos Editorial; 2004. p.478.</mixed-citation>
        <element-citation publication-type="book">
          <source>Temas de marca-passo</source>
          <date>
            <year>2004</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Melo</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Baldasseroni S, Opasich C, Gorini G, Lucci D, Marchionni N, Marini M, et al. Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143(3):398-405.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>398</fpage>
          <lpage>405</lpage>
          <issue>3</issue>
          <volume>143</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Baldasseroni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Opasich</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gorini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lucci</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Marchionni</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol. 2005;46(12):2183-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Significance of QRS complex duration in patients with heart failure</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2183</fpage>
          <lpage>92</lpage>
          <issue>12</issue>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kashani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Barold</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Prinzen FW, Augustijn CH, Arts T, Allessie MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol Heart Circ Physiol. 1990;259(2 Pt 2):H300-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Redistribution of myocardial fiber strain and blood flow by asynchronous activation</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <date>
            <year>1990</year>
          </date>
          <fpage>H300</fpage>
          <lpage>8</lpage>
          <issue>2 Pt 2</issue>
          <volume>259</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Prinzen</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Augustijn</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Arts</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Allessie</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Reneman</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Vernooy K, Verbeek XA, Peschar M, Prinzen FW. Relation between abnormal ventricular impulse conduction and heart failure. J Interv Cardiol. 2003;16(6):557-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Relation between abnormal ventricular impulse conduction and heart failure</article-title>
          <source>J Interv Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>557</fpage>
          <lpage>62</lpage>
          <issue>6</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vernooy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Verbeek</surname>
              <given-names>XA</given-names>
            </name>
            <name>
              <surname>Peschar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Prinzen</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Dilaveris P, Pantazis A, Giannopoulos G, Synetos A, Gialafos J, Stefanadis C. Upgrade to biventricular pacing in patients with pacing-induced heart failure: can resynchronization do the trick? Europace. 2006;8(5):352-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Upgrade to biventricular pacing in patients with pacing-induced heart failure: can resynchronization do the trick?</article-title>
          <source>Europace</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>352</fpage>
          <lpage>7</lpage>
          <issue>5</issue>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dilaveris</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pantazis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giannopoulos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Synetos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gialafos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stefanadis</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Gorcsan J 3rd, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, et al. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr. 2008;21(3):191-213.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society</article-title>
          <source>J Am Soc Echocardiogr</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>191</fpage>
          <lpage>213</lpage>
          <issue>3</issue>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gorcsan 3rd</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Agler</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Derumeaux</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Grimm</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Ribeiro AL, dos Reis AM, Barros MV, de Sousa MR, Rocha AL, Perez AA, et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet. 2002;360(9331):461-2.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease</article-title>
          <source>Lancet</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>461</fpage>
          <lpage>2</lpage>
          <issue>9331</issue>
          <volume>360</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>dos Reis</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>de Sousa</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40(5):976-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Plasma brain natriuretic peptide concentration: impact of age and gender</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>976</fpage>
          <lpage>82</lpage>
          <issue>5</issue>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Redfield</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Rodeheffer</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Jacobsen</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Burnett Jr</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357-68.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Natriuretic peptides</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2357</fpage>
          <lpage>68</lpage>
          <issue>25</issue>
          <volume>50</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Daniels</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Maisel</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346(24):1854-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ventricular pacing or dual-chamber pacing for sinus-node dysfunction</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>1854</fpage>
          <lpage>62</lpage>
          <issue>24</issue>
          <volume>346</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lamas</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Sweeney</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Silverman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial</article-title>
          <source>JAMA</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>3115</fpage>
          <lpage>23</lpage>
          <issue>24</issue>
          <volume>288</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wilkoff</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Hallstrom</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Hsia</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, McNitt S, et al; MADIT II Investigators. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol. 2005;16(4):359-65.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>359</fpage>
          <lpage>65</lpage>
          <issue>4</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Steinberg</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schuger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Daubert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McNitt</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107(23):2932-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2932</fpage>
          <lpage>7</lpage>
          <issue>23</issue>
          <volume>107</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sweeney</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Hellkamp</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Ellenbogen</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Greenspon</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony. J Am Coll Cardiol. 2009;54(9):764-76.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effects of right ventricular apical pacing on ventricular function and dyssynchrony</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>764</fpage>
          <lpage>76</lpage>
          <issue>9</issue>
          <volume>54</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tops</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Schalij</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Silva RT, Martinelli F&#351; M, Oliveira JC, Lima CEB, Martins DGMC, Guir&#227;o CI, et al. Remodelamento ventricular na estimula&#231;&#227;o card&#237;aca apical do ventr&#237;culo direito. Arq Bras Cardiol. 2007;88(2):152-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Remodelamento ventricular na estimula&#231;&#227;o card&#237;aca apical do ventr&#237;culo direito</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>152</fpage>
          <lpage>8</lpage>
          <issue>2</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Martinelli F&#186;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>CEB</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>DGMC</given-names>
            </name>
            <name>
              <surname>Guir&#227;o</surname>
              <given-names>CI</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Chiladakis JA, Koutsogiannis N, Kalogeropoulos A, Zagli F, Arvantis P, Alexopoulos D. Unfavourable effects of continuous, atrial-synchronised ventricular pacing on ventricular systolic and diastolic function in patients with normal left ventricular ejection fraction: usefulness of tissue and colour Doppler echocardiography. Hellenic J Cardiol. 2007;48(6):335-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Unfavourable effects of continuous, atrial-synchronised ventricular pacing on ventricular systolic and diastolic function in patients with normal left ventricular ejection fraction: usefulness of tissue and colour Doppler echocardiography</article-title>
          <source>Hellenic J Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>335</fpage>
          <lpage>40</lpage>
          <issue>6</issue>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chiladakis</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Koutsogiannis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kalogeropoulos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Arvantis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Alexopoulos</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Kawanish Y, Ito T, Suwa M, Terasaki F, Futal R, Kitaura Y. Effect of left ventricular dyssynchrony on plasma B-type natriuretic peptide levels in patients with long-term right ventricular apical pacing. Int Heart J. 2008;49(2):165-73.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of left ventricular dyssynchrony on plasma B-type natriuretic peptide levels in patients with long-term right ventricular apical pacing</article-title>
          <source>Int Heart J</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>165</fpage>
          <lpage>73</lpage>
          <issue>2</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kawanish</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suwa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Terasaki</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Futal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kitaura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Xue-Hua Z, Chen H, Chung-Wah S, Kai-Hang Y, Wing-Sze C, Kathy LL. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade AV block and normal left ventriculr function. J Cardiovasc Electrophysiol. 2008;19(2):136-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade AV block and normal left ventriculr function</article-title>
          <source>J Cardiovasc Electrophysiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>136</fpage>
          <lpage>41</lpage>
          <issue>2</issue>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Xue-Hua</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chung-Wah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kai-Hang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wing-Sze</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kathy</surname>
              <given-names>LL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Abraham J, Abraham TP. Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available. Circ Cardiovasc Imaging. 2008;1(1):79-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy: Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available</article-title>
          <source>Circ Cardiovasc Imaging</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>79</fpage>
          <lpage>84</lpage>
          <issue>1</issue>
          <volume>1</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539-49.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effect of cardiac resynchronization on morbidity and mortality in heart failure</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1539</fpage>
          <lpage>49</lpage>
          <issue>15</issue>
          <volume>352</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cleland</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Daubert</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Erdmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Freemantle</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gras</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kappenberger</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. S&#225; LAB, Rassi S, Batista MAL. Conventional ventricular stimulation effects on patients with normal ventricular function. Arq Bras Cardiol. 2009;93(2):167-73.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Conventional ventricular stimulation effects on patients with normal ventricular function</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>167</fpage>
          <lpage>73</lpage>
          <issue>2</issue>
          <volume>93</volume>
          <person-group person-group-type="author">
            <name>
              <surname>S&#225;</surname>
              <given-names>LAB</given-names>
            </name>
            <name>
              <surname>Rassi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Batista</surname>
              <given-names>MAL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Results of the Predictors of Response to CRT (PROSPECT) trial</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>2608</fpage>
          <lpage>16</lpage>
          <issue>20</issue>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Tavazzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Nihoyannopoulos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Merlino</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24.  Beshai JF, Grimm RA, Nagueh SF, Baker JH 2nd, Beau SL, Greenberg SM, et al; RethinQ Study Investigators. Cardiac resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357(24):2461-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac resynchronization therapy in heart failure with narrow QRS complexes</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2461</fpage>
          <lpage>71</lpage>
          <issue>24</issue>
          <volume>357</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Beshai</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Grimm</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Nagueh</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Baker 2nd</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Beau</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm. 2008;5(6):934-55.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons: ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary</article-title>
          <source>Heart Rhythm</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>934</fpage>
          <lpage>55</lpage>
          <issue>6</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Epstein</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Dimarco</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Ellenbogen</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Estes 3rd</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Freedman</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Gettes</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Cleland JGF, Tageldien A, Buga L, Wong K, Gorcsan J 3rd. Should we be trying to define responders to cardiac resynchronization therapy? JACC Cardiovasc Imaging. 2010;3(5):541-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Should we be trying to define responders to cardiac resynchronization therapy</article-title>
          <source>JACC Cardiovasc Imaging</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>541</fpage>
          <lpage>9</lpage>
          <issue>5</issue>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cleland</surname>
              <given-names>JGF</given-names>
            </name>
            <name>
              <surname>Tageldien</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Buga</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gorcsan 3rd</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Ventricular dyssynchrony and increased BNP levels in right ventricular apical pacing</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Long-term right ventricular apical pacing can cause ventricular dyssynchrony and, secondarily, neurohumoral alterations and increase in cardiac morbimortality. OBJECTIVE: To analyze ventricular dyssynchrony and its effects on BNP levels in patients with pacemakers and long-term right ventricular (RV) apex pacing. METHODS: Cross-sectional study of 85 patients with single or dual chamber pacemaker, NYHA functional class I or II and left ventricular ejection fraction (LVEF) &gt; 35%. The dyssynchrony assessment was carried out using several echocardiographic techniques, including Tissue Synchronization Imaging (TSI), with the analysis of the 12 segments. BNP was measured at the same time when the echocardiogram was performed, but the examiner was blinded to the results. RESULTS: Forty-six women and 39 men, aged 58 &#177; 12 years, with Chagas' disease (56%) and controlled hypertensive individuals (62%), were included in the study. LVEF was 52 &#177; 8% and the mean QRS duration was 139 ms (120-180 ms). BNP levels were altered in 36.5% of the sample (cutoff = 60 pg/ml). At the multivariate linear regression analysis, BNP was correlated with age (p = 0.024), LVEF (p &lt; 0.0001) and left ventricular (LV) pre-ejection time (p = 0.009), which is an intraventricular dyssynchrony index. CONCLUSION: In clinically stable patients receiving conventional cardiac pacing, the intraventricular dyssynchrony was an independent predictor of BNP level increase after adjusted for age and LVEF.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Pacemaker</kwd>
        <kwd>artificial</kwd>
        <kwd>ventricular dysfunction</kwd>
        <kwd>natriuretic peptides</kwd>
        <kwd>echocardiography</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p><undefined id="tx-body2"/>Ventricular dyssynchrony and increased BNP levels in right ventricular apical pacing</p>
      <p>
        <bold>Cl&#225;udia Drummond Guimar&#227;es Abreu<sup>I</sup>; Maria do Carmo Pereira Nunes<sup>I,II</sup>; M&#225;rcia Melo Barbosa<sup>I</sup>; Manoel Ot&#225;vio Costa Rocha<sup>I</sup>; Ant&#244;nio Luiz Pinho Ribeiro<sup>I</sup></bold>
      </p>
      <p><sup>I</sup>Hospital das Cl&#237;nicas e Faculdade de Medicina da UFMG</p>
      <p><sup>II</sup>Departamento de Ecocardiografia do Hospital Socor, Belo Horizonte, MG - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Long-term right ventricular apical pacing can cause ventricular dyssynchrony and, secondarily, neurohumoral alterations and increase in cardiac morbimortality.</p>
      <p><bold>OBJECTIVE:</bold> To analyze ventricular dyssynchrony and its effects on BNP levels in patients with pacemakers and long-term right ventricular (RV) apex pacing.</p>
      <p><bold>METHODS:</bold> Cross-sectional study of 85 patients with single or dual chamber pacemaker, NYHA functional class I or II and left ventricular ejection fraction (LVEF) <underline>&gt;</underline> 35%. The dyssynchrony assessment was carried out using several echocardiographic techniques, including Tissue Synchronization Imaging (TSI), with the analysis of the 12 segments. BNP was measured at the same time when the echocardiogram was performed, but the examiner was blinded to the results.</p>
      <p><bold>RESULTS:</bold> Forty-six women and 39 men, aged 58 &#177; 12 years, with Chagas' disease (56%) and controlled hypertensive individuals (62%), were included in the study. LVEF was 52 &#177; 8% and the mean QRS duration was 139 ms (120-180 ms). BNP levels were altered in 36.5% of the sample (cutoff = 60 pg/ml). At the multivariate linear regression analysis, BNP was correlated with age (p = 0.024), LVEF (p &lt; 0.0001) and left ventricular (LV) pre-ejection time (p = 0.009), which is an intraventricular dyssynchrony index.</p>
      <p><bold>CONCLUSION:</bold> In clinically stable patients receiving conventional cardiac pacing, the intraventricular dyssynchrony was an independent predictor of BNP level increase after adjusted for age and LVEF. </p>
      <p><bold>Keywords:</bold> Pacemaker, artificial; ventricular dysfunction; natriuretic peptides; echocardiography.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Currently, cardiac pacemakers (PM) represent an effective treatment for symptomatic bradycardias cause by sinus node disease (SND) and atrioventricular block (AVB). For many years, the apical region of the right ventricle (RV) was one of the most frequently used sites in conventional implants due to its accessibility and lead cable stability<sup>1</sup>. However, in spite of the evident improvement in quality of life for most patients with an artificial implant, the left bundle-branch block (LBBB) induced by right ventricular apical pacing (RVAP) can cause hemodynamic, structural and functional alterations in the heart, with deleterious consequences on the clinical evolution of some patients<sup>2,3</sup>. </p>
      <p>The cardiac pacing at any point of the ventricle alters the natural heart activation and contraction pattern, as the stimulus conduction velocity is slower across the ventricular myocardium, when compared to that resulting from the specialized His-Purkinje system<sup>4</sup>. </p>
      <p>Studies have demonstrated that, in response to an artificial pacing, the myocardial fibers contract erratically, resulting in heterogeneous stretching of myocardial segments that can interfere with the metabolism of the cardiac cell and cause global deterioration of the organ function<sup>5,6</sup>. Hence, it could be presupposed that an abnormal electrical ventricular activation sequence associated to the inappropriate stretching of ventricular walls could result in dyssynchrony between the electrical ventricular activity and its contractility, determining, in the long term, ventricular dysfunction, neurohumoral alterations and increased cardiac morbidity and mortality. </p>
      <p>Based on this hypothesis, the main objective of the present study was to evaluate the presence of ventricular dyssynchrony (VD) after long-term RVAP and its effects on brain natriuretic peptide (BNP) levels in clinically stable patients with no significant LV dysfunctions.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>The study was carried out at the Pacemaker Laboratory of the Service of Cardiology of <italic>Hospital das Cl&#237;nicas da Universidade Federal de Minas Gerais</italic> (UFMG) and the Echocardiography Center of Hospital Socor, after approval by the Ethical Committee of UFMG and the hospitals involved in the study. All patients signed the Free and Informed Consent form.</p>
      <p>From June 2007 to March 2008, 85 Chagasic and non-Chagasic patients were consecutively selected during routine telemetric assessments carried out at the aforementioned laboratory, who had been submitted to single or dual-chamber pacemaker implantation with RVAP, and depended on artificial pacing (percentage of RV pacing <underline>&gt;</underline> 80%) , with a LBBB pattern of ventricular activation at the surface electrocardiogram (ECG).</p>
      <p>Patients of both sexes aged 18 to 75 years, with NYHA functional class I or II and left ventricular ejection fraction (LVEF) <underline>&gt;</underline> 35% were included. Preexisting diseases and medications currently being used were identified. </p>
      <p>Systemic arterial hypertension (SAH) was defined as a clinical history of hypertension and systolic blood pressure (SBP) levels <underline>&gt;</underline> 140 mmHg or diastolic blood pressure (DBP) <underline>&gt;</underline> 90 mmHg. Only controlled hypertensive and normotensive individuals were included in the study. </p>
      <p>Diabetes mellitus was defined as a clinical history of diabetes and regular use of oral hypoglycemiants and/or insulin and only diabetic patients with controlled glycemic levels were included in the study. </p>
      <p>Chagas' disease was identified by the presence of at least two distinct positive serological tests (ELISA, indirect hemagglutination or indirect immunofluorescence test) and relevant epidemiological history.</p>
      <p>Kidney function was assessed through creatinine level measurement requested by the assistant physicians during the routine clinical/cardiologic follow-up.</p>
      <p>The exclusion criteria considered coronary artery disease, characterized by the presence of chest angina and/or evidence of LV segmental contractility impairment at the echocardiogram, atrial fibrillation (AF), chronic obstructive pulmonary disease (COPD), pregnancy, recent heart surgery (less than 4 weeks) or refusal to participate in the study. </p>
      <p>
        <bold>Analysis of the QRS complex and chest X-ray</bold>
      </p>
      <p>The duration of the QRS complex consisted in the measurement of the time interval between the emission of the pacemaker spike and the end of the QRS complex (ms), assessed at the surface ECG D2 derivation.</p>
      <p>The position of the ventricular lead-electrode was verified through a chest X-ray in the posteroanterior and profile views. </p>
      <p>
        <bold>Echocardiographic study</bold>
      </p>
      <p>The echocardiographic study protocol consisted in obtaining one and two-dimensional images with pulsed and continuous Doppler guided by color flow mapping, in addition to tissue Doppler, including Tissue Synchronization Imaging (TSI), with analysis of 12 segments.</p>
      <p>The evaluations were carried out by en experienced professional in a Vivid 7 equipment (GE Vingmed Ultrasound AS, Horten, Norway), equipped with an electronic transducer of variable frequency (4 to 12 MHz) and high resolution.</p>
      <p>Ventricular dyssynchrony was analyzed through different echocardiographic techniques, according to the recommendations of the current Consensus of the American Society of Echocardiography<sup>7</sup>. The following measurements were obtained: </p>
      <disp-quote>
        <p><italic>1. DifLV-RVPET</italic> - Difference between pre-ejection time of left and right ventricles (interventricular delay) obtained by pulsed Doppler (cutoff <underline>&gt;</underline> 40 ms);</p>
        <p><italic>2. IVSPW delay - </italic>Contraction delay between the interventricular septum and the posterior wall in M mode (cutoff <underline>&gt;</underline> 130 ms);</p>
        <p><italic>3. LVPET -</italic> LV pre-ejection time measurement (aortic) at pulsed Doppler (cutoff <underline>&gt;</underline> 140 ms); </p>
        <p><italic>4. MaxDif12seg -</italic> Maximum difference of time between two distinct segments obtained with TSI technique (cutoff &gt;100 ms);</p>
        <p><italic>5. SD12seg -</italic> Analysis of the standard deviation of the aforementioned 12 segments (cutoff &gt; 32.6 ms);</p>
        <p><italic>6. IVSLW delay -</italic> Contraction delay between the interventricular septum and the lateral wall also obtained through TSI (cutoff <underline>&gt;</underline> 65 ms);</p>
      </disp-quote>
      <p>
        <bold>BNP measurement</bold>
      </p>
      <p>BNP measurement was carried out in a venous blood sample, preferably obtained from the antecubital vein with the patient in the supine position for 30 minutes, before the echocardiogram was performed, with the examiner blinded for the results. Blood pressure (BP) and heart rate (HR) were measured before the collection. The whole blood samples were collected into plastic tubes containing EDTA (1 mg/ml of blood) and immediately processed using the Triage<sup>TM</sup> BNP Test kits (Biosite<sup>TM</sup> Inc., San Diego, USA). In the present study, the cutoff was defined as 60 pg/ml for BNP levels, which was based on previous studies of Chagasic patients with preserved LV function<sup>8,9</sup>.</p>
      <p>
        <bold>Statistical analysis </bold>
      </p>
      <p>The categorical variables were described by proportions and the continuous by means and standard deviations, medians and interquartile intervals, according to the distribution pattern. Uni- and multivariate linear regression analyses were used, considering BNP levels as the dependent variable. The level of statistical significance was defined for p values &lt; 0.05.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Only clinically compensated patients with NYHA functional class I or II were included in the study. There was a predominance of dual-chamber pacing (74%) and the median implant time was 63 months (1 - 137 months), and 94% of the sample had been undergoing artificial pacing for six months or more. Total Atrioventricular Block (TAVB) was the most common indication for the implant (85%) and in 48 patients (56%) Chagas' disease was the cause of the underlying heart disease. The mean QRS duration was 139 &#177; 14.2 ms and none of the patients had significant LV dysfunction (mean LVEF = 51.8 &#177; 8%). </p>
      <p>Regarding the RV, its mean performance indices were within the normal range, even after the analysis of the subgroup of patients with LVEF <underline>&lt;</underline> 40%. Its mean ejection fraction was 56.4 &#177; 11.2%. </p>
      <p>BNP level median was 38.9 pg/ml with a minimum measured level of 5 pg/ml and a maximum level of 581 pg/ml. In 34 patients (40%), these levels were considered to be high (cutoff = 60 pg/ml). The main clinical and demographic characteristics and echocardiographic parameters are shown in <xref ref-type="table" rid="tab01-body2">Table 1</xref>. </p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt01-en.jpg"/></table-wrap>
      <p>Interventricular dyssynchrony was observed in 49 patients (59.8%), considering the median of the interventricular delay. Significant intraventricular dyssynchrony was observed in 77 patients (90.6%), when the analyzed parameter was the median of the LV pre-ejection time, as well as when the standard deviation and the maximum difference of systolic peaks measured in the 12 myocardial segments were analyzed. Similarly, the median of the contraction delay between the interventricular septum and the lateral wall was significant in 31 patients (36.5%) (<xref ref-type="table" rid="tab02-body2">Table 2</xref>).</p>
      <table-wrap id="tab02-body2">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt02-en.jpg"/></table-wrap>
      <p>At the univariate analysis, the QRS duration, time of implant, Chagas disease, arterial hypertension and most of the echocardiographic variables did not have a significant correlation with BNP levels. However, age (r = 0.33, p = 0.002) and LVEF (r = -0.28, p = 0.010) were significantly correlated with this parameter. A significant correlation was also observed between the measurement of the LV pre-ejection time (r = 0.27, p = 0.013) and BNP levels (<xref ref-type="fig" rid="fig01-body2">Figure 1</xref>). All other measurements performed to assess VD did not show a significant correlation with BNP levels, regardless of the echocardiographic technique used (<xref ref-type="table" rid="tab03-body2">Table 3</xref>). The positive association between LVPET and BNP levels remained even when the first was analyzed as a categorical variable, using the cutoff recommended for the diagnosis of VD according to the current literature (<underline>&gt;</underline> 140 ms) (<xref ref-type="fig" rid="fig02-body2">Figure 2</xref>). </p>
      <fig id="fig01-body2">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gf01-en.jpg"/></fig>
      <table-wrap id="tab03-body2">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt03-en.jpg"/></table-wrap>
      <fig id="fig02-body2">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gf02-en.jpg"/></fig>
      <p>At the multiple linear regression analysis, the LVPET remained as the only significant and independent predictor of BNP levels, even after adjustment for covariables, such as age and LVEF. Therefore, the linear regression model obtained disclosed that the older the patient, the more severe the LV dysfunction and the longer the LV pre-ejection time (starting at 140 ms), on average, the higher the BNP levels. </p>
      <p>Although it was not the main objective of the present study, an analysis between the subgroups of Chagasic and Non-Chagasic patients was performed, as well as between the different pacing modes, DDD and VVI. However, no significant differences were observed in this series between the groups when the clinical, electrocardiographic and echocardiographic variables were evaluated, except for the mean LVEF, which was lower in Chagasic patients (p = 0,035).</p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The present study showed a high frequency of VD in patients with pacemakers submitted to long-term right ventricular apical pacing who were clinically stable, in addition to a significant correlation between the LV pre-ejection time, which is a measure of intraventricular dyssynchrony and BNP levels. </p>
      <p>The study group was characterized by age of 58.5 &#177; 12.6 years, predominance of Chagasic patients and absence of significant ventricular dysfunction (LVEF: 51.8 &#177; 8.5%). The regular use of medications such as ACE inhibitors, beta-blockers and diuretics by more than 80% of the assessed patients indicates that all were submitted to optimized clinical treatment and were NYHA functional class I or II. </p>
      <p>Around 40% of the patients had high levels of BNP, considering 60 pg/ml the cutoff used for the measured levels. This information was based on a previous study that analyzed Chagasic patients with preserved ventricular function and observed similar mean BNP levels between the control group and patients with LVEF &gt; 40%. Significantly higher levels were found in patients with LVEF <underline>&lt;</underline> 40%<sup>8</sup>.</p>
      <p>In accordance with other studies<sup>9,10</sup>, it was observed that an increase in BNP levels was correlated with an increase in age (r = 0.33, p = 0.002) and LVEF worsening (r = -0.28, p = 0.010). However, considering that most of the sample was NYHA functional class I, more than the increase in LV filling pressures, the VD observed in the study also contributed to the increase in BNP levels. This fact was demonstrated by the significant correlation between the LV pre-ejection time and BNP (r = 0.38, p &lt; 0.0001), regardless of LVEF and age.</p>
      <p>Previous studies have demonstrated that dyssynchronous ventricular activation can contribute to asymmetric hypertrophy, myofibrillar disarray, increase in catecholamine concentrations, neurohumoral activation and regional perfusion disorders<sup>5</sup>. The studies MOST<sup>11</sup>, DAVID<sup>12 </sup>and MADIT II<sup>13</sup>, in turn, indicated that VD can create an anatomofunctional substrate capable of impairing heart function in the long term, by observing an increase in the risk of AF, mitral regurgitation and hospital admissions due to heart failure in patients with a high percentage of right ventricular paced beats, particularly those with ventricular dysfunction prior to the implant<sup>14</sup>. However, whether VD is an acute phenomenon that could deteriorate LV function in the long term and, consequently, result in HF in the absence of cardiomyopathy, remains to be clarified<sup>15,16</sup>. </p>
      <p>Our results are in accordance, however, with those of other studies that verified that VD secondary to long-term RVAP can impair the LV systolic and diastolic functions and contribute to the increase in BNP levels. According to Chiladakis et al<sup>17</sup>, the increase in the left ventricular-end systolic volume and isovolumetric relaxation time caused by RVAP in patients with normal LVEF contributed to these findings. Other authors also verified a significant correlation between BNP levels and VD severity detected in patients with RVAP, as well as initial signs of HF in patients with TAVB and normal LVEF, after RVAP for 6.5 &#177; 5.7 years<sup>18,19</sup>.</p>
      <p>Currently, the VD caused by RVAP can be quantified by several echocardiographic techniques. Although many types of measurements can be used, the most simple and routine ones have shown a good performance in multicentric assessments<sup>20</sup>. The LV pre-ejection time, for instance, assessed in the present study, is useful to quantify intraventricular dyssynchrony with good reproducibility according to previous studies, such as the CARE-HF study<sup>21</sup>. Recently, S&#225; et al<sup>22</sup> observed the prolonging of this measurement in a small group of patients, who were also Chagasic with normal LVEF, throughout an eight-month period. The authors observed that although the LVPET measurements did not reach the cutoff required for the diagnosis of VD (<underline>&gt;</underline> 140 ms), this was the only assessed VD measure that showed increases throughout follow-up. It is noteworthy the fact that, in the aforementioned study, the septal pacing predominated over the apical one, which seems to be more deleterious.</p>
      <p>In addition to LVPET, which was altered in more than 90% of the sample, the other echocardiographic measures assessed in the study also identified inter- and intraventricular dyssynchrony alterations, disclosing the high frequency of this disorder in patients submitted to long-term RVAP. Indices such as the interventricular delay, maximum difference and standard deviation of the 12 segments were altered in more than 50% of the sample. However, in spite of the usefulness of the several echocardiographic techniques employed, including Tissue Synchronization Imaging, to quantify VD, no significant association between these measures and BNP serum levels were observed in this group of patients, in opposition to LVPET. </p>
      <p>Our results corroborate current discussions, especially in the field of CRT, which aim at answering whether the echocardiographic measures used to date in the analysis of VD are the ones that can better define its presence. Two important prospective and multicentric studies, PROSPECT<sup>23 </sup>and ReThinQ<sup>24</sup>, did not find any correlation between VD measures and the benefits of CRT when selecting candidates to the procedure according to echocardiographic criteria. The importance of technical factors that contribute for these findings has been highlighted, especially by aspects related to the feasibility and reproducibility of the methods used. It is a consensus, however, that the TSI technique must not be considered unproductive for the VD analysis, but technological advances are necessary for less operator-dependent approaches<sup>20</sup>.</p>
      <p>
        <bold>Limitations</bold>
      </p>
      <p>As this is a cross-sectional study, patients with PM were assessed at a certain point during their clinical follow-up, which brings limitations to the results. Although our findings indicate an association between the increase in BNP levels and VD secondary to long-term RVAP, the study design does not allow us to establish a causal association between these variables. </p>
      <p>It is important to consider that BNP was assessed together with the VD measures, of which specific studies did not define the best indices or ideal cutoffs to perform its analysis and this is one of the reasons of the non-inclusion of the dyssynchrony measures proposed, until then, by the current Cardiac Resynchronization Guidelines<sup>25</sup>. In spite of that, it is a consensus in the current literature that the VD measures be used together with clinical criteria in the selection of candidates considered to be borderline for CRT<sup>26</sup>.</p>
      <p>Limitations that are inherent to the Tissue Synchronization Imaging must be mentioned<sup>7</sup>. Among them are the systolic curves, not always contained within the ejection interval, multiple peaks resulting from a same myocardial segment and, in some instances, instead of a well-defined peak, the presence of a plateau, which made it difficult to determine the ideal point for the proposed measure. </p>
      <p>
        <bold>Conclusions</bold>
      </p>
      <p>Patients with PM and long-term RVAP have a high frequency of VD and in the present study, the intraventricular dyssynchrony was identified through the measurement of the LVPET in around 90% of the patients. Moreover, this measure showed to be an independent predictor of increased BNP levels, indicating that VD was capable of producing early neurohumoral alterations in patients with no significant LV dysfunction. </p>
      <p>Further studies are necessary to define whether the VD identified at the echocardiogram or the increase in BNP levels in patients with PM submitted to long-term RVAP are capable of predicting an unfavorable evolution. </p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Claudia Drummond Guimar&#227;es Abreu, from <italic>Universidade Federal de Minas Gerais</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Disincron&#237;a ventricular y aumento de los niveles de BNP en la estimulaci&#243;n apical del ventr&#237;culo derecho</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La estimulaci&#243;n apical cr&#243;nica del ventr&#237;culo derecho puede ocasionar disincron&#237;a ventricular y, secundariamente, alteraciones neurohumorales y aumento de la morbimortalidad card&#237;aca. OBJETIVO: Investigar disincron&#237;a ventricular y sus efectos sobre los niveles de BNP en pacientes con marcapasos estimulados cr&#243;nicamente en el &#225;pice del ventr&#237;culo derecho (VD). M&#201;TODOS: Estudio transversal con 85 pacientes con marcapasos uni o bicameral, en clase funcional I y II de la NYHA y fracci&#243;n de eyecci&#243;n del ventr&#237;culo izquierdo (FEVI) &gt; 35%. La evaluaci&#243;n de disincron&#237;a fue realizada utilizando varias t&#233;cnicas ecocardiogr&#225;ficas, incluyendo el Tissue Synchronization Imaging (TSI), con an&#225;lisis de los 12 segmentos. El BNP fue dosado junto con el ecocardiograma, aunque con el examinador ciego. RESULTADOS: Cuarenta y seis mujeres y 39 hombres, con edad de 58 &#177; 12 a&#241;os, chag&#225;sicos (56%) e hipertensos controlados (62%), fueron incluidos. La fracci&#243;n de eyecci&#243;n del VI fue 52 &#177; 8% y la duraci&#243;n media del QRS de 139 ms (120-180 ms). El BNP se mostr&#243; alterado en 36,5% de la muestra (punto de corte de 60 pg/ml). En el an&#225;lisis multivariado de regresi&#243;n lineal, el BNP se correlacion&#243; con la edad (p = 0,024), FEVI (p &lt; 0,0001) y tiempo pre-eyectivo del VI (p = 0,009), que es &#237;ndice de disincron&#237;a intraventricular. CONCLUSI&#211;N: En pacientes con estimulaci&#243;n card&#237;aca convencional, estables cl&#237;nicamente, la disincron&#237;a intraventricular fue un predictor independiente del aumento de los niveles de BNP, despu&#233;s de ajuste por edad y FEVI.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Marcapasos artificial</kwd>
        <kwd>disfunci&#243;n ventricular</kwd>
        <kwd>p&#233;ptidos natriur&#233;ticos</kwd>
        <kwd>ecocardiograf&#237;a</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ESPECIAL</bold>
      </p>
      <p>
        <fn id="nota_1-body3">
          <label>
            <bold>Disincron&#237;a ventricular y aumento de los niveles de BNP en la estimulaci&#243;n apical del ventr&#237;culo derecho</bold>
          </label>
          <p>
            <bold>Cl&#225;udia Drummond Guimar&#227;es Abreu<sup>I</sup>; Maria do Carmo Pereira Nunes<sup>I,II</sup>; M&#225;rcia Melo Barbosa<sup>II</sup>; Manoel Ot&#225;vio Costa Rocha<sup>I</sup>; Ant&#244;nio Luiz Pinho Ribeiro<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital das Cl&#237;nicas e Faculdade de Medicina da UFMG</p>
      <p><sup>II</sup>Departamento de Ecocardiografia do Hospital Socor, Belo Horizonte, MG - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> La estimulaci&#243;n apical cr&#243;nica del ventr&#237;culo derecho puede ocasionar disincron&#237;a ventricular y, secundariamente, alteraciones neurohumorales y aumento de la morbimortalidad card&#237;aca.</p>
      <p><bold>OBJETIVO:</bold> Investigar disincron&#237;a ventricular y sus efectos sobre los niveles de BNP en pacientes con marcapasos estimulados cr&#243;nicamente en el &#225;pice del ventr&#237;culo derecho (VD).</p>
      <p><bold>M&#201;TODOS:</bold> Estudio transversal con 85 pacientes con marcapasos uni o bicameral, en clase funcional I y II de la NYHA y fracci&#243;n de eyecci&#243;n del ventr&#237;culo izquierdo (FEVI) <underline>&gt;</underline> 35%. La evaluaci&#243;n de disincron&#237;a fue realizada utilizando varias t&#233;cnicas ecocardiogr&#225;ficas, incluyendo el <italic>Tissue Synchronization Imaging </italic>(TSI), con an&#225;lisis de los 12 segmentos. El BNP fue dosado junto con el ecocardiograma, aunque con el examinador ciego.</p>
      <p><bold>RESULTADOS:</bold> Cuarenta y seis mujeres y 39 hombres, con edad de 58 &#177; 12 a&#241;os, chag&#225;sicos (56%) e hipertensos controlados (62%), fueron incluidos. La fracci&#243;n de eyecci&#243;n del VI fue 52 &#177; 8% y la duraci&#243;n media del QRS de 139 ms (120-180 ms). El BNP se mostr&#243; alterado en 36,5% de la muestra (punto de corte de 60 pg/ml). En el an&#225;lisis multivariado de regresi&#243;n lineal, el BNP se correlacion&#243; con la edad (p = 0,024), FEVI (p &lt; 0,0001) y tiempo pre-eyectivo del VI (p = 0,009), que es &#237;ndice de disincron&#237;a intraventricular.</p>
      <p><bold>CONCLUSI&#211;N:</bold> En pacientes con estimulaci&#243;n card&#237;aca convencional, estables cl&#237;nicamente, la disincron&#237;a intraventricular fue un predictor independiente del aumento de los niveles de BNP, despu&#233;s de ajuste por edad y FEVI. (Arq Bras Cardiol 2011; 97(2) : 156-162)</p>
      <p><bold>Palabras clave:</bold> Marcapasos artificial, disfunci&#243;n ventricular, p&#233;ptidos natriur&#233;ticos, ecocardiograf&#237;a.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>Actualmente, los marcapasos card&#237;acos (MP) representan tratamiento efectivo para las bradicardias sintom&#225;ticas causadas por enfermedad del n&#243;dulo sinusal (ENS) y bloqueos atrioventriculares (BAV). Durante muchos a&#241;os, la regi&#243;n apical del ventr&#237;culo derecho (VD) fue uno de los sitios m&#225;s utilizados en los implantes convencionales por su facilidad de acceso y estabilidad del cable electrodo<sup>1</sup>. Entre tanto, a pesar de la evidente mejora de la calidad de vida en la mayor&#237;a de los portadores del implante artificial, el bloqueo de rama izquierdo (BRI) inducido por la estimulaci&#243;n apical del ventr&#237;culo derecho (EAPVD) puede ocasionar alteraciones hemodin&#225;micas, estructurales y funcionales del coraz&#243;n, con consecuencias delet&#233;reas sobre la evoluci&#243;n cl&#237;nica de algunos pacientes<sup>2,3</sup>.</p>
      <p>La estimulaci&#243;n card&#237;aca en cualquier punto del ventr&#237;culo altera el est&#225;ndar natural de activaci&#243;n y contracci&#243;n card&#237;acas, ya que la velocidad de conducci&#243;n del est&#237;mulo es m&#225;s lenta a trav&#233;s del miocardio ventricular si es comparada a la efectuada por el sistema especializado His-Purkinje<sup>4</sup>.</p>
      <p>Estudios ya demostraron que, en respuesta al est&#237;mulo artificial, las fibras mioc&#225;rdicas se contraen de manera desorganizada, provocando estiramientos heterog&#233;neos de segmentos mioc&#225;rdicos que pueden interferir en el metabolismo de la c&#233;lula card&#237;aca y causar deterioro global del funcionamiento del &#243;rgano<sup>5,6</sup>. Por lo tanto, podr&#237;amos presuponer que una secuencia el&#233;ctrica anormal de activaci&#243;n ventricular asociada al estiramiento inapropiado de las paredes del ventr&#237;culo podr&#237;a causar disincronismo entre la actividad el&#233;ctrica ventricular y su contractilidad, determinando, a largo plazo, disfunci&#243;n ventricular, alteraciones neurohumorales y aumento de la morbilidad y mortalidad card&#237;acas.</p>
      <p>Basado en esa hip&#243;tesis, el principal objetivo del estudio consisti&#243; en evaluar la presencia de disincron&#237;a ventricular despu&#233;s de la EAPVD cr&#243;nica y sus efectos sobre los niveles de BNP, en pacientes estables cl&#237;nicamente y sin disfunci&#243;n importante del VI.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>El estudio fue realizado en el Laboratorio de Marcapasos del Servicio de Cardiolog&#237;a del Hospital de Cl&#237;nicas de la Universidad Federal de Minas Gerais (UFMG) y en el Centro de Ecocardiograf&#237;a del Hospital Socor, despu&#233;s de ser aprobado por los Comit&#233;s de &#201;tica de la UFMG y de los hospitales participantes. Todos los pacientes firmaron el t&#233;rmino de consentimiento libre y aclarado.</p>
      <p>En el per&#237;odo de junio de 2007 a marzo de 2008, fueron seleccionados consecutivamente durante las evaluaciones telem&#233;tricas de rutina realizadas en el referido Laboratorio, 85 pacientes portadores de marcapasos uni o bicamerales con estimulaci&#243;n apical del VD, chag&#225;sicos y no chag&#225;sicos, dependientes de estimulaci&#243;n artificial (porcentual de estimulaci&#243;n de VD <underline>&gt;</underline> 80%) y con est&#225;ndar de activaci&#243;n ventricular tipo BRI en el electrocardiograma (ECG) de superficie.</p>
      <p>Fueron incluidos pacientes de ambos sexos de 18 a 75 a&#241;os, en clase funcional I y II de la NYHA y con fracci&#243;n de eyecci&#243;n del ventr&#237;culo izquierdo (FEVI) <underline>&gt;</underline> 35%. Las enfermedades preexistentes y medicaciones en uso fueron identificadas.</p>
      <p>Hipertensi&#243;n arterial sist&#233;mica (HAS) fue definida como historia cl&#237;nica de hipertensi&#243;n y valores de presi&#243;n arterial sist&#243;lica (PAS) <underline>&gt;</underline> 140 mmHg o de presi&#243;n arterial diast&#243;lica (PAD) <underline>&gt;</underline> 90 mmHg. Fueron incluidos solamente hipertensos controlados o normotensos.</p>
      <p>Diabetes mellitus fue definida como historia cl&#237;nica de diabetes y uso regular de hipoglucemiantes orales y/o insulina, siendo incluidos solamente diab&#233;ticos con niveles gluc&#233;micos controlados.</p>
      <p>La enfermedad de Chagas fue identificada por la presencia de por lo menos dos ex&#225;menes serol&#243;gicos distintos positivos (ELISA, hemaglutinaci&#243;n indirecta o inmunofluorescencia indirecta) e historia epidemiol&#243;gica relevante.</p>
      <p>La funci&#243;n renal fue evaluada por medio del dosaje de creatinina solicitada por los m&#233;dicos asistentes, durante el seguimiento cl&#237;nico/cardiol&#243;gico de rutina.</p>
      <p>Los criterios de exclusi&#243;n consideraron enfermedad arterial coronaria caracterizada por la presencia de angina de pecho y/o evidencia de d&#233;ficit segmentario de la contractilidad del VI al ecocardiograma, fibrilaci&#243;n atrial (FA), enfermedad pulmonar (EPOC), gravidez, cirug&#237;a card&#237;aca reciente (menos de cuatro semanas) o rechazo a participar del estudio.</p>
      <p>
        <bold>An&#225;lisis del complejo QRS y radiograf&#237;a del t&#243;rax</bold>
      </p>
      <p>La duraci&#243;n del complejo QRS consisti&#243; en la medida del intervalo de tiempo entre la emisi&#243;n de la esp&#237;cula del marcapasos y el final del complejo QRS (ms), evaluada en la derivaci&#243;n D2 del electrocardiograma de superficie (ECG).</p>
      <p>El posicionamiento del cable electrodo ventricular fue verificado por medio de radiograf&#237;a de t&#243;rax en las incidencias p&#243;stero-anterior y perfil.</p>
      <p>
        <bold>Estudio ecocardiogr&#225;fico</bold>
      </p>
      <p>El protocolo del estudio ecocardiogr&#225;fico const&#243; de obtenci&#243;n de im&#225;genes uni y bidimensionales, con Doppler pulsado y continuo guiado por mapeo de flujo en colores, adem&#225;s del Doppler tisular, incluyendo el <italic>Tissue Synchronization Imaging </italic>(TSI), con an&#225;lisis de los 12 segmentos.</p>
      <p>Los ex&#225;menes fueron realizados por profesional experimentado en aparato de la marca Vivid 7 (GE Vingmed Ultrasound AS, Horten, Noruega), equipado con transductor electr&#243;nico de frecuencia variable (4 a 12 MHz) y alta resoluci&#243;n.</p>
      <p>La disincron&#237;a ventricular fue analizada mediante diferentes t&#233;cnicas ecocardiogr&#225;ficas, respetando las recomendaciones del actual Consenso de la Sociedad Americana de Ecocardiograf&#237;a<sup>7</sup>. Las siguientes medidas fueron realizadas:</p>
      <disp-quote>
        <p><italic>1. DifTPEVI-VD -</italic>Diferencia entre los tiempos pre-eyectivos del VI y VD (atraso interventricular) obtenidos por medio del Doppler puls&#225;til (punto de corte <underline>&gt;</underline> 40 ms);</p>
        <p><italic>2. Retardo SIVPP -</italic>Atraso de contracci&#243;n entre el septo interventricular y la pared posterior al modo M (punto de corte: <underline>&gt;</underline> 130 ms);</p>
        <p><italic>3. TPEVI -</italic>Medida del tiempo pre-eyectivo del VI (a&#243;rtico) al Doppler puls&#225;til (punto de corte: <underline>&gt;</underline> 140 ms);</p>
        <p><italic>4. MaxDif12seg -</italic>M&#225;xima diferencia de tiempo entre dos segmentos distintos obtenidos con la t&#233;cnica del TSI (punto de corte: &gt;100 ms);</p>
        <p><italic>5. DP12seg -</italic>An&#225;lisis del desv&#237;o est&#225;ndar de los 12 segmentos supracitados (punto de corte &gt; 32,6 ms);</p>
        <p><italic>6. Retardo SIVPL -</italic>Atraso de contracci&#243;n entre el septo interventricular y la pared lateral obtenida tambi&#233;n por el TSI (punto de corte: <underline>&gt;</underline> 65 ms);</p>
      </disp-quote>
      <p>
        <bold>Dosaje del BNP</bold>
      </p>
      <p>El dosaje del BNP fue realizado a partir de la colecta de sangre venosa, de preferencia en vena antecubital, con el paciente en posici&#243;n supina por 30 minutos, antes de la realizaci&#243;n del ecocardiograma y con el examinador ciego para sus resultados. La presi&#243;n arterial y la frecuencia card&#237;aca fueron medidas antes de la colecta. Las muestras de sangre total fueron colocadas en tubos de pl&#225;stico conteniendo EDTA (1 mg/ml de sangre) y procesadas inmediatamente por intermedio de los kits del <italic>Triage<sup>&#174;</sup> BNP Test </italic>(Biosite<sup>&#174; </sup>Inc., San Diego, EUA). En el presente estudio, se defini&#243; el punto de corte de 60 pg/ml para los niveles de BNP, bas&#225;ndose ese valor en trabajos anteriores envolviendo chag&#225;sicos con funci&#243;n de VI preservada<sup>8,9</sup>.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Las variables categ&#243;ricas fueron descriptas por las proporciones, las continuas, por las medias y desv&#237;os-est&#225;ndar, medianas e intervalos intercuart&#237;licos, seg&#250;n est&#225;ndar de distribuci&#243;n. Se utiliz&#243; an&#225;lisis de regresi&#243;n lineal uni y multivariada considerando como variable dependiente el BNP. El nivel de significaci&#243;n estad&#237;stica fue definido para valores de p menores que 0,05.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Fueron incluidos solamente pacientes cl&#237;nicamente compensados, en clase funcional I y II de la NYHA. Hubo predominio del modo de estimulaci&#243;n doble c&#225;mara (74%) y el tiempo mediano del implante fue de 63 meses (1 -137 meses), y 94% de la muestra se presentaban en estimulaci&#243;n artificial por seis meses o m&#225;s. El Bloqueo Atrioventricular Total (BAVT) fue la indicaci&#243;n m&#225;s com&#250;n para el implante (85%) y en 48 pacientes (56%) la enfermedad de Chagas se present&#243; como la causa de la cardiopat&#237;a de base. La duraci&#243;n media del QRS fue de 139 &#177; 14,2 ms y ninguno de los pacientes present&#243; disfunci&#243;n significativa del VI (FEVI media = 51,8 &#177; 8%).</p>
      <p>Con relaci&#243;n al VD, las medias de sus &#237;ndices de desempe&#241;o se presentaron dentro de los limites normales, aun despu&#233;s de an&#225;lisis del subgrupo de pacientes con FEVI <underline>&lt;</underline> 40%. Su fracci&#243;n de eyecci&#243;n media fue de 56,4 &#177; 11,2%.</p>
      <p>La mediana de los niveles de BNP fue de 38,9 pg/ml con valor m&#237;nimo dosado de 5 pg/ml y m&#225;ximo de 581 pg/ml. En 34 pacientes (40%), esos niveles fueron considerados elevados (punto de corte de 60 pg/ml). Las principales caracter&#237;sticas cl&#237;nicas, demogr&#225;ficas y par&#225;metros ecocardiogr&#225;ficos evaluados est&#225;n listados en la <xref ref-type="table" rid="tab1-body3">tabla 1</xref>.</p>
      <table-wrap id="tab1-body3">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt01-es.jpg"/></table-wrap>
      <p>La disincron&#237;a interventricular fue observada en 49 pacientes (59,8%), consider&#225;ndose la mediana del atraso interventricular. Disincron&#237;a intraventricular significativa fue observada en 77 pacientes (90,6%) cuando el par&#225;metro analizado fue la mediana del tiempo pre-eyectivo del VI, as&#237; como cuando se analiz&#243; el desv&#237;o-est&#225;ndar y la diferencia m&#225;xima de los picos sist&#243;licos medidos en los 12 segmentos mioc&#225;rdicos. De la misma forma, la mediana del atraso de contracci&#243;n entre el septo interventricular y la pared lateral fue significativa en 31 pacientes (36,5%) (<xref ref-type="table" rid="tab2-body3">tab. 2</xref>).</p>
      <table-wrap id="tab2-body3">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt02-es.jpg"/></table-wrap>
      <p>En el an&#225;lisis univariado, la duraci&#243;n del QRS, el tiempo de implante, la enfermedad de Chagas, la hipertensi&#243;n arterial y la mayor parte de las variables ecocardiogr&#225;ficas no presentaron correlaci&#243;n significativa con los niveles de BNP. Entre tanto, edad (r = 0,33, p = 0,002) y FEVI (r = -0,28, p = 0,010) se correlacionaron significativamente con ese par&#225;metro. Correlaci&#243;n significativa tambi&#233;n fue observada entre la medida del tiempo pre-eyectivo del VI (r = 0,27, p = 0,013) y el BNP (<xref ref-type="fig" rid="es_a10fig01-body3">fig. 1</xref>). Todas las otras medidas realizadas para evaluaci&#243;n de DV no mostraron correlaci&#243;n significativa con los niveles del p&#233;ptido en cuesti&#243;n, independientemente de la t&#233;cnica ecocardiogr&#225;fica empleada (<xref ref-type="table" rid="tab3-body3">tab. 3</xref>). La asociaci&#243;n positiva entre el TPEVI y los niveles de BNP permaneci&#243; aun cuando el primero fue analizado como una variable categ&#243;rica, utilizando el punto de corte recomendado para el diagn&#243;stico de DV seg&#250;n la literatura actual (<underline>&gt;</underline> 140 ms) (<xref ref-type="fig" rid="es_a10fig02-body3">fig. 2</xref>).</p>
      <p content-type="asset">
        <fig id="es_a10fig01-body3">
          <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gf01-es.jpg"/></fig>
      </p>
      <p content-type="asset">
        <fig id="es_a10fig02-body3">
          <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gf02-es.jpg"/></fig>
      </p>
      <table-wrap id="tab3-body3">
        <graphic xlink:href="1678-4170-abc-97-02-0156-00070-gt03-es.jpg"/></table-wrap>
      <p>En el an&#225;lisis de regresi&#243;n lineal m&#250;ltiple, el TPEVI permaneci&#243; como &#250;nico predictor significativo e independiente de los niveles de BNP, aun despu&#233;s de ajuste para covariables, como edad y FEVI. El modelo de regresi&#243;n lineal obtenido revel&#243;, por lo tanto, que cuanto mayor fuese el paciente; cuanto m&#225;s grave fuese la disfunci&#243;n del VI y m&#225;s prolongado el tiempo pre-eyectivo del ventr&#237;culo izquierdo (a partir de 140 ms), en media, mayores ser&#237;an los niveles de BNP.</p>
      <p>Aunque no haya sido objetivo principal del estudio, fue realizado an&#225;lisis entre los subgrupos de chag&#225;sicos y no chag&#225;sicos, y tambi&#233;n entre los diferentes modos de estimulaci&#243;n, DDD y VVI. Entre tanto, no se observaron en esta serie diferencias significativas entre los grupos cuando las variables cl&#237;nicas, electrocardiogr&#225;ficas y ecocardiogr&#225;ficas fueron evaluadas, excepto la media de la FEVI, que fue menor en los chag&#225;sicos (p = 0,035).</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El presente estudio demostr&#243; la elevada frecuencia de DV en pacientes con MP estimulados cr&#243;nicamente en el &#225;pice del VD y estables cl&#237;nicamente, adem&#225;s de una correlaci&#243;n significativa entre el tiempo pre-eyectivo del VI, que es una medida de disincron&#237;a intraventricular, y los niveles de BNP.</p>
      <p>El grupo estudiado se caracteriz&#243; por edad de 58,5 &#177; 12,6 a&#241;os, predominio de chag&#225;sicos y ausencia de disfunci&#243;n ventricular importante (FEVI: 51,8 &#177; 8,5%). El uso regular de drogas como los inhibidores de la ECA, betabloqueantes y diur&#233;ticos en m&#225;s de 80% de los pacientes evaluados indica que todos estaban en tratamiento cl&#237;nico optimizado, en clase funcional I y II de la NYHA.</p>
      <p>Cerca de 40% de los pacientes presentaron niveles elevados de BNP, consider&#225;ndose 60 pg/ml el punto de corte para los valores dosados. Se bas&#243; ese dato en estudio previo que analiz&#243; chag&#225;sicos con funci&#243;n ventricular preservada y observ&#243; valores medios de BNP semejantes entre el grupo control y pacientes con FEVI &gt; 40%. Niveles significativamente mayores fueron encontrados en los pacientes con FEVI <underline>&lt;</underline> 40%<sup>8</sup>.</p>
      <p>En concordancia con otros trabajos9,10, se observ&#243; que la elevaci&#243;n de los niveles de BNP se correlacion&#243; con el aumento de la edad (r = 0,33, p = 0,002) y con el empeoramiento de la FEVI (r = -0,28, p = 0,010). Entre tanto, considerando que la mayor parte de la muestra se presentaba en clase funcional I de la NYHA, m&#225;s que el aumento de las presiones de llenado del VI, la DV observada en el estudio tambi&#233;n contribuy&#243; para la elevaci&#243;n de los niveles de BNP. Hecho demostrado mediante la correlaci&#243;n significativa entre el tiempo pre-eyectivo del VI y el BNP (r = 0,38, p &lt; 0,0001), independientemente de la FEVI y edad.</p>
      <p>Trabajos anteriores ya verificaron que la activaci&#243;n disincr&#243;nica de los ventr&#237;culos puede contribuir a una hipertrofia asim&#233;trica, desarreglo miofibrilar, aumento de la concentraci&#243;n de catecolaminas, activaci&#243;n neurohumoral y disturbios de perfusi&#243;n regional<sup>5</sup>. Los estudios MOST<sup>11</sup>, DAVID<sup>12</sup> y MADIT II<sup>13</sup>, a su vez, indicaron que la DV puede crear substrato an&#225;tomo-funcional capaz de comprometer la funci&#243;n card&#237;aca a largo plazo al constatar aumento del riesgo de FA, insuficiencia mitral y hospitalizaciones por IC en pacientes con elevado porcentaje de latidos estimulados en el VD, particularmente en aquellos con disfunci&#243;n ventricular previa al implante<sup>14</sup>. Entre tanto, aun no est&#225; claro si la DV es un fen&#243;meno agudo que podr&#237;a deteriorar la funci&#243;n del VI a largo plazo y, consecuentemente, ocasionar IC en ausencia de cardiomiopat&#237;a<sup>15,16</sup>.</p>
      <p>Nuestros resultados concuerdan, sin embargo, con otros trabajos que verificaron que la DV secundaria a EAPVD cr&#243;nica puede ocasionar da&#241;os en la funci&#243;n sist&#243;lica y diast&#243;lica del VI y contribuir para el aumento de los niveles de BNP. Seg&#250;n Chiladakis et al<sup>17</sup>, el incremento del volumen sist&#243;lico final del VI y del tiempo de relajaci&#243;n isovolum&#233;trico ocasionados por la EAPVD, en pacientes con FEVI normal, contribuy&#243; a esos hallazgos. Otros autores tambi&#233;n verificaron correlaci&#243;n significativa del BNP con la gravedad de la DV detectada en pacientes con EAPVD, as&#237; como s&#237;ntomas iniciales de IC en pacientes con BAVT y FEVI normal, despu&#233;s de EAPVD por 6,5 &#177; 5,7 anos<sup>18,19</sup>.</p>
      <p>Actualmente, la DV ocasionada por la EAPVD puede ser cuantificada por varias t&#233;cnicas ecocardiogr&#225;ficas. Aunque muchas medidas puedan ser utilizadas, las m&#225;s simples y rutinarias han presentado buen desempe&#241;o en evaluaciones multic&#233;ntricas<sup>20</sup>. El tiempo pre-eyectivo del VI, por ejemplo, evaluado en el presente estudio, es &#250;til para cuantificar disincron&#237;a intraventricular con buena reproductibilidad seg&#250;n trabajos previos, como el estudio CARE-HF<sup>21</sup>. Recientemente, S&#225; et al22 observaron prolongaci&#243;n de esa medida en un peque&#241;o grupo de pacientes, tambi&#233;n, de mayor&#237;a chag&#225;sica con FEVI normal, a lo largo de ocho meses. Los autores verificaron que a pesar de que las medidas del TPEVI no alcanzaron el valor aceptado para el diagn&#243;stico de DV (<underline>&gt;</underline> 140 ms), esa fue la &#250;nica medida de DV analizada que present&#243; incrementos a lo largo del tiempo de control. Se destaca que, en el estudio en cuesti&#243;n, la estimulaci&#243;n septal predomin&#243; sobre la apical, que parece ser m&#225;s delet&#233;rea.</p>
      <p>Adem&#225;s del TPEVI, alterado en m&#225;s de 90% de la muestra, las dem&#225;s medidas ecocardiogr&#225;ficas evaluadas en el estudio tambi&#233;n identificaron alteraciones disincr&#243;nicas inter y intraventriculares, revelando la elevada frecuencia de ese disturbio en pacientes con EAPVD cr&#243;nica. &#205;ndices tales como el atraso interventricular, la m&#225;xima diferencia y el desv&#237;o est&#225;ndar de los 12 segmentos se presentaron alterados en m&#225;s de 50% de la muestra. Entre tanto, a pesar de la utilidad de las diversas t&#233;cnicas ecocardiogr&#225;ficas empleadas, incluyendo la <italic>Tissue Synchronization Imaging</italic>, para cuantificar la DV, no se evidenci&#243; asociaci&#243;n significativa de esas medidas con los niveles s&#233;ricos de BNP en ese grupo de pacientes, al contrario del TPEVI.</p>
      <p>Nuestros resultados corroboran las discusiones actuales, especialmente en el campo de la TRC, que buscan responder si las medidas ecocardiogr&#225;ficas utilizadas, hasta el momento, para el an&#225;lisis de DV, ser&#237;an aquellas que mejor definir&#237;an su presencia. De los importantes estudios prospectivos y multic&#233;ntricos, el PROSPECT<sup>23 </sup>y el ReThinQ<sup>24</sup>, no encontraron correlaci&#243;n entre las medidas de DV y los beneficios de la TRC al seleccionar candidatos al procedimiento seg&#250;n criterios ecocardiogr&#225;ficos. La importancia de factores t&#233;cnicos contribuyendo para esos hallazgos fue destacada, en especial, por aspectos relacionados a la exequibilidad y reproductibilidad de los m&#233;todos utilizados. Es consenso, entre tanto, que la t&#233;cnica del TSI no deba ser considerada improductiva para el an&#225;lisis de DV, m&#225;s avances tecnol&#243;gicos son necesarios para abordajes menos dependientes del operador<sup>20 </sup>.</p>
      <p>
        <bold>Limitaciones</bold>
      </p>
      <p>Por tratarse de estudio transversal, fueron evaluados pacientes con MP en un determinado momento de su seguimiento cl&#237;nico, lo que acarrea limitaciones en los resultados. Aunque nuestros hallazgos indiquen asociaci&#243;n entre la elevaci&#243;n de los niveles de BNP y DV secundaria a la EAPVD cr&#243;nica, el dise&#241;o del estudio no permite establecer una relaci&#243;n causal entre esas variables.</p>
      <p>Es importante considerar, aun, que el BNP fue evaluado en conjunto con medidas de DV cuyos trabajos espec&#237;ficos no definieron cuales ser&#237;an los mejores &#237;ndices o puntos de cortes ideales para su an&#225;lisis, siendo ese uno de los motivos de la no inclusi&#243;n de las medidas de disincron&#237;a propuestas, hasta entonces, en las Directrices actuales de resincronizaci&#243;n card&#237;aca<sup>25</sup>. A pesar de eso, es consenso en la literatura actual que las medidas de DV sean utilizadas en conjunto con los criterios cl&#237;nicos en la selecci&#243;n de candidatos considerados lim&#237;trofes para la TRC<sup>26</sup>.</p>
      <p>Limitaciones inherentes a la t&#233;cnica de la <italic>Tissue Synchronization Imaging </italic>deben ser resaltadas<sup>7</sup>. Se destacan, entre ellas, curvas sist&#243;licas no siempre contenidas dentro del intervalo eyectivo, m&#250;ltiples picos resultantes de un mismo segmento mioc&#225;rdico y, en algunas ocasiones, en vez de un pico bien definido, una meseta, que dificultaba la determinaci&#243;n del punto ideal para la medida propuesta.</p>
      <p>
        <bold>Conclusiones</bold>
      </p>
      <p>Pacientes con MP estimulados cr&#243;nicamente en el &#225;pice del VD presentan elevada frecuencia de DV, y en el presente estudio la disincron&#237;a intraventricular fue identificada por medio de la medida del tiempo pre-eyectivo del VI, en cerca de 90% de los pacientes. Adem&#225;s de eso, esa medida mostr&#243; ser un predictor independiente del aumento de los niveles de BNP, indicando que la DV fue capaz de producir alteraciones neurohumorales precozmente en pacientes sin disfunci&#243;n importante del VI. Nuevos estudios son necesarios para definir si la DV identificada al ecocardiograma o el aumento de los niveles de BNP, en pacientes con MP estimulados cr&#243;nicamente en el &#225;pice del VD, son capaces de predecir evoluci&#243;n desfavorable.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de Disertaci&#243;n de Maestr&#237;a de Claudia Drummond Guimar&#227;es Abreu, por la <italic>Universidade Federal de Minas Gerais</italic>.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
